<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><submitter>Yin K</submitter><funding>NCRR NIH HHS</funding><funding>NIDDK NIH HHS</funding><funding>NIAID NIH HHS</funding><funding>NIH HHS</funding><pubmed_abstract>Long COVID (LC), a type of post-acute sequelae of SARS-CoV-2 infection (PASC), occurs after at least 10% of SARS-CoV-2 infections, yet its etiology remains poorly understood. Here, we used multiple "omics" assays (CyTOF, RNAseq/scRNAseq, Olink) and serology to deeply characterize both global and SARS-CoV-2-specific immunity from blood of individuals with clear LC and non-LC clinical trajectories, 8 months following infection and prior to receipt of any SARS-CoV-2 vaccine. Our analysis focused on deep phenotyping of T cells, which play important roles in immunity against SARS-CoV-2 yet may also contribute to COVID-19 pathogenesis. Our findings demonstrate that individuals with LC exhibit systemic inflammation and immune dysregulation. This is evidenced by global differences in T cell subset</pubmed_abstract><journal>bioRxiv : the preprint server for biology</journal><pagination>2023.02.09.527892</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9934605</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Long COVID manifests with T cell dysregulation, inflammation, and an uncoordinated adaptive immune response to SARS-CoV-2.</pubmed_title><pmcid>PMC9934605</pmcid><funding_grant_id>P30 DK063720</funding_grant_id><funding_grant_id>K23 AI146268</funding_grant_id><funding_grant_id>R01 AI141003</funding_grant_id><funding_grant_id>S10 OD018040</funding_grant_id><funding_grant_id>K23 AI157875</funding_grant_id><funding_grant_id>L30 AI126521</funding_grant_id><funding_grant_id>L30 AI147159</funding_grant_id><funding_grant_id>S10 RR028962</funding_grant_id><funding_grant_id>R01 AI158013</funding_grant_id><pubmed_authors>Anglin K</pubmed_authors><pubmed_authors>Standker L</pubmed_authors><pubmed_authors>Peluso MJ</pubmed_authors><pubmed_authors>Ma T</pubmed_authors><pubmed_authors>Lopez M</pubmed_authors><pubmed_authors>Asare K</pubmed_authors><pubmed_authors>Thomas R</pubmed_authors><pubmed_authors>Munch J</pubmed_authors><pubmed_authors>Henrich TJ</pubmed_authors><pubmed_authors>Andrew A</pubmed_authors><pubmed_authors>Argueta U</pubmed_authors><pubmed_authors>Deveau TM</pubmed_authors><pubmed_authors>Huang B</pubmed_authors><pubmed_authors>Roan NR</pubmed_authors><pubmed_authors>Lee SA</pubmed_authors><pubmed_authors>Neidleman J</pubmed_authors><pubmed_authors>Martin JN</pubmed_authors><pubmed_authors>Valdivieso D</pubmed_authors><pubmed_authors>Munter SE</pubmed_authors><pubmed_authors>Shin MG</pubmed_authors><pubmed_authors>Ibrahim R</pubmed_authors><pubmed_authors>Lu S</pubmed_authors><pubmed_authors>Lynch KL</pubmed_authors><pubmed_authors>Hoh R</pubmed_authors><pubmed_authors>Kelly JD</pubmed_authors><pubmed_authors>Luo X</pubmed_authors><pubmed_authors>Young K</pubmed_authors><pubmed_authors>Goldberg SA</pubmed_authors><pubmed_authors>Yin K</pubmed_authors><pubmed_authors>Deeks SG</pubmed_authors></additional><is_claimable>false</is_claimable><name>Long COVID manifests with T cell dysregulation, inflammation, and an uncoordinated adaptive immune response to SARS-CoV-2.</name><description>Long COVID (LC), a type of post-acute sequelae of SARS-CoV-2 infection (PASC), occurs after at least 10% of SARS-CoV-2 infections, yet its etiology remains poorly understood. Here, we used multiple "omics" assays (CyTOF, RNAseq/scRNAseq, Olink) and serology to deeply characterize both global and SARS-CoV-2-specific immunity from blood of individuals with clear LC and non-LC clinical trajectories, 8 months following infection and prior to receipt of any SARS-CoV-2 vaccine. Our analysis focused on deep phenotyping of T cells, which play important roles in immunity against SARS-CoV-2 yet may also contribute to COVID-19 pathogenesis. Our findings demonstrate that individuals with LC exhibit systemic inflammation and immune dysregulation. This is evidenced by global differences in T cell subset</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Aug</publication><modification>2026-04-08T13:39:19.478Z</modification><creation>2024-12-03T18:09:18.8Z</creation></dates><accession>S-EPMC9934605</accession><cross_references><pubmed>36798286</pubmed><doi>10.1101/2023.02.09.527892</doi></cross_references></HashMap>